Manufacturer Provide Pharmaceutical Intermediate Repaglinide Powder CAS 135062-02-1 Repaglinide

Introduction

Product Name: Repaglinide

Other Name :2-ETHOXY-4-[2-[(1S)-3-METHYL-1-[2-(1-PIPERIDINYL)BUTYL]AMINO]-2-OXOETHYL]-BENZOIC ACID

CAS NO:135062-02-1

Purity: 99%min
Appearance:White crystalline powder

Molecular formula: C27H36N2O4

MW:452.59

Melting Point :129-130.2 °C

Boiling Point :672.9±55.0 °C(Predicted)

Density :1.137±0.06 g/cm3(Predicted)

Storage :Keep in dark place,Inert atmosphere,Room temperature

Repaglinide causes blood sugar levels to drop rapidly.  Repaglinide tablet is a commonly used hypoglycemic drug, which is a non-sulfonylurea hypoglycemic drug.  Its main function is to reduce the blood glucose level rapidly by stimulating the pancreas, and this effect depends on the functional beta cells in the pancreas.
Repaglinide tablet is mainly used for some patients through diet control, through effective exercise to reduce weight, still can not effectively control high blood sugar in some type 2 diabetes patients.  In addition, it can also be combined with metformin to treat high blood sugar, the method of taking is to be taken within 15 minutes before meals, the dosage is different according to each person's blood sugar level, the general starting dose is 0.5 mg orally, the specific use, we must use under the guidance of a doctor.

Application

The main functions and effects of repaglinide are as follows:
1.  Lower blood sugar levels: Repaglinide can reduce the release of glucose from the liver and increase the absorption and utilization of glucose by muscle and fat cells, thereby reducing blood sugar levels.
2.   Improve sensitivity:  Repaglinide can improve the sensitivity of cells, enhance the action,  so that the body can better use glucose.
3.   Reduce cardiovascular risk:  Repaglinide can reduce the risk of cardiovascular disease and prevent complications such as heart disease and stroke.